Skip to main content
letter
. 2020 Jun 3;81(2):e139–e141. doi: 10.1016/j.jinf.2020.05.068

Fig. 1.

Fig 1

(A) Incidence of cardiovascular complications in COVID-19 patients; (B) Incidence of myocardial injury in COVID-19 patients, by clinically relevant characteristics

CI, confidence interval (bars); CVD, cardiovascular disease; DIC, disseminated intravascular coagulation; PE, pulmonary embolism; VTE, venous thromboembolism; *, p-value for meta-regression